AAAAAA

   
Results: 1-22 |
Results: 22
ADENOSARCOMA OF THE UTERUS FOLLOWING TAMOXIFEN TREATMENT FOR BREAST-CANCER
Authors: MOURITS MJE HOLLEMA H WILLEMSE PHB DEVRIES EGE AALDERS JG VANDERZEE AGJ
Citation: Mje. Mourits et al., ADENOSARCOMA OF THE UTERUS FOLLOWING TAMOXIFEN TREATMENT FOR BREAST-CANCER, International journal of gynecological cancer, 8(2), 1998, pp. 168-171
SERUM AND CYSTIC FLUID LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR-ALPHAIN PATIENTS WITH EPITHELIAL OVARIAN-TUMORS ARE CORRELATED
Authors: DEBRUIJN HWA TENHOOR KA VANDERZEE AGJ
Citation: Hwa. Debruijn et al., SERUM AND CYSTIC FLUID LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR-ALPHAIN PATIENTS WITH EPITHELIAL OVARIAN-TUMORS ARE CORRELATED, Tumor biology, 19(3), 1998, pp. 160-166
TELOMERASE ACTIVITY AS A BIOMARKER FOR (PRE)NEOPLASTIC CERVICAL DISEASE IN SCRAPINGS AND FROZEN-SECTIONS FROM PATIENTS WITH ABNORMAL CERVICAL SMEAR
Authors: WISMAN GBA HOLLEMA H DEJONG S TERSCHEGGET J TJONGAHUNG SP RUITERS MHJ KRANS M DEVRIES EGE VANDERZEE AGJ
Citation: Gba. Wisman et al., TELOMERASE ACTIVITY AS A BIOMARKER FOR (PRE)NEOPLASTIC CERVICAL DISEASE IN SCRAPINGS AND FROZEN-SECTIONS FROM PATIENTS WITH ABNORMAL CERVICAL SMEAR, Journal of clinical oncology, 16(6), 1998, pp. 2238-2245
SENTINEL LYMPH-NODE IDENTIFICATION WITH TC-99M-LABELED NANOCOLLOID INSQUAMOUS-CELL CANCER OF THE VULVA
Authors: DEHULLU JA DOTING E PIERS D HOLLEMA H AALDERS JG KOOPS HS BOONSTRA H VANDERZEE AGJ
Citation: Ja. Dehullu et al., SENTINEL LYMPH-NODE IDENTIFICATION WITH TC-99M-LABELED NANOCOLLOID INSQUAMOUS-CELL CANCER OF THE VULVA, The Journal of nuclear medicine, 39(8), 1998, pp. 1381-1385
HOMOZYGOUS ARGININE-72 IN WILD-TYPE P53 AND RISK OF CERVICAL-CANCER
Authors: HAYES VM HOFSTRA RMW BUYS CHCM HOLLEMA H VANDERZEE AGJ
Citation: Vm. Hayes et al., HOMOZYGOUS ARGININE-72 IN WILD-TYPE P53 AND RISK OF CERVICAL-CANCER, Lancet, 352(9142), 1998, pp. 1756-1756
LAPAROSCOPIC PLACEMENT OF PAP CATHETERS FOR INTRAPERITONEAL CHEMOTHERAPY IN OVARIAN-CARCINOMA
Authors: ARTS HJG WILLEMSE PHB TINGA DJ DEVRIES EGE VANDERZEE AGJ
Citation: Hjg. Arts et al., LAPAROSCOPIC PLACEMENT OF PAP CATHETERS FOR INTRAPERITONEAL CHEMOTHERAPY IN OVARIAN-CARCINOMA, Gynecologic oncology, 69(1), 1998, pp. 32-35
THE VALUE OF CANCER ANTIGEN-125 (CA-125) DURING TREATMENT AND FOLLOW-UP OF PATIENTS WITH OVARIAN-CANCER
Authors: DEBRUIJN HWA VANDERZEE AGJ AALDERS JG
Citation: Hwa. Debruijn et al., THE VALUE OF CANCER ANTIGEN-125 (CA-125) DURING TREATMENT AND FOLLOW-UP OF PATIENTS WITH OVARIAN-CANCER, Current opinion in obstetrics & gynecology, 9(1), 1997, pp. 8-13
A PHASE-II STUDY OF PRIMARY INTRAPERITONEAL PACLITAXEL COMBINED WITH CBDCA CYTOXAN (CC) IN PRIMARY OC/
Authors: WILLEMSE PHB HOFSTRA L BEIJNEN JH DEVRIES EGE VANDERZEE AGJ VANDERGRAAF WTA BOONSTRA H SLEIJFER DT PIERS DA MULDER NH
Citation: Phb. Willemse et al., A PHASE-II STUDY OF PRIMARY INTRAPERITONEAL PACLITAXEL COMBINED WITH CBDCA CYTOXAN (CC) IN PRIMARY OC/, European journal of cancer, 33, 1997, pp. 534-534
EXPRESSION OF MACROPHAGE-COLONY-STIMULATING FACTOR (M-CSF), INTERLEUKIN-6 (IL-6), INTERLEUKIN-1-BETA (IL-1-BETA), INTERLEUKIN-11 (IL-11) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN P53-CHARACTERIZED HUMAN OVARIAN CARCINOMAS
Authors: ASSCHERT JGW VELLENGA E HOLLEMA H VANDERZEE AGJ DEVRIES EGE
Citation: Jgw. Asschert et al., EXPRESSION OF MACROPHAGE-COLONY-STIMULATING FACTOR (M-CSF), INTERLEUKIN-6 (IL-6), INTERLEUKIN-1-BETA (IL-1-BETA), INTERLEUKIN-11 (IL-11) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN P53-CHARACTERIZED HUMAN OVARIAN CARCINOMAS, European journal of cancer, 33(13), 1997, pp. 2246-2251
HMLH1 EXPRESSION AND CELLULAR-RESPONSES OF OVARIAN TUMOR-CELLS TO TREATMENT WITH CYTOTOXIC ANTICANCER AGENTS
Authors: BROWN R HIRST GL GALLAGHER WM MCILWRATH AJ MARGISON GP VANDERZEE AGJ ANTHONEY DA
Citation: R. Brown et al., HMLH1 EXPRESSION AND CELLULAR-RESPONSES OF OVARIAN TUMOR-CELLS TO TREATMENT WITH CYTOTOXIC ANTICANCER AGENTS, Oncogene, 15(1), 1997, pp. 45-52
RISING SERUM VALUES OF BETA-SUBUNIT HUMAN CHORIONIC-GONADOTROPIN (HCG) IN PATIENTS WITH PROGRESSIVE VULVAR CARCINOMAS
Authors: DEBRUIJN HWA TENHOOR KA KRANS M VANDERZEE AGJ
Citation: Hwa. Debruijn et al., RISING SERUM VALUES OF BETA-SUBUNIT HUMAN CHORIONIC-GONADOTROPIN (HCG) IN PATIENTS WITH PROGRESSIVE VULVAR CARCINOMAS, British Journal of Cancer, 75(8), 1997, pp. 1217-1218
PRETREATMENT SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN - A NEWLY IDENTIFIED PROGNOSTIC FACTOR IN EARLY-STAGE CERVICAL-CARCINOMA
Authors: DUK JM GROENIER KH DEBRUIJN HWA HOLLEMA H TENHOOR KA VANDERZEE AGJ AALDERS JG
Citation: Jm. Duk et al., PRETREATMENT SERUM SQUAMOUS-CELL CARCINOMA ANTIGEN - A NEWLY IDENTIFIED PROGNOSTIC FACTOR IN EARLY-STAGE CERVICAL-CARCINOMA, Journal of clinical oncology, 14(1), 1996, pp. 111-118
DETECTION OF GROIN METASTASES IN PATIENTS WITH VULVAR CANCER, USING L-[1-C-11] TYROSINE (TYR) POSITRON EMISSION TOMOGRAPHY
Authors: PRUIM J VANDERZEE AGJ HOLLEMA H ESHUIS SA BOONSTRA H VAALBURG W
Citation: J. Pruim et al., DETECTION OF GROIN METASTASES IN PATIENTS WITH VULVAR CANCER, USING L-[1-C-11] TYROSINE (TYR) POSITRON EMISSION TOMOGRAPHY, The Journal of nuclear medicine, 37(5), 1996, pp. 1179-1179
T-CELL TELOMERE LENGTH IN HIV-1 INFECTION - NO EVIDENCE FOR INCREASEDCD4(-CELL TURNOVER() T)
Authors: WOLTHERS KC WISMAN GBA OTTO SA HUSMAN AMD SCHAFT N DEWOLF F GOUDSMIT J COUTINHO RA VANDERZEE AGJ MEYAARD L MIEDEMA F
Citation: Kc. Wolthers et al., T-CELL TELOMERE LENGTH IN HIV-1 INFECTION - NO EVIDENCE FOR INCREASEDCD4(-CELL TURNOVER() T), Science, 274(5292), 1996, pp. 1543-1547
DRUG RESISTANCE-ASSOCIATED MARKER LRP FOR PREDICTION OF RESPONSE TO CHEMOTHERAPY AND PROGNOSES IN ADVANCED OVARIAN-CARCINOMA
Authors: IZQUIERDO MA VANDERZEE AGJ VERMORKEN JB VANDERVALK P BELIEN JAM GIACCONE G SCHEFFER GL FLENS MJ PINEDO HM KENEMANS P MEIJER CJLM DEVRIES EGE SCHEPER RJ
Citation: Ma. Izquierdo et al., DRUG RESISTANCE-ASSOCIATED MARKER LRP FOR PREDICTION OF RESPONSE TO CHEMOTHERAPY AND PROGNOSES IN ADVANCED OVARIAN-CARCINOMA, Journal of the National Cancer Institute, 87(16), 1995, pp. 1230-1237
PHASE-II STUDY OF INTRAPERITONEAL CISPLATIN PLUS SYSTEMIC ETOPOSIDE AS 2ND-LINE TREATMENT IN PATIENTS WITH SMALL-VOLUME RESIDUAL OVARIAN-CANCER
Authors: DEJONG RS WILLEMSE PHB BOONSTRA H DEVRIES EGE VANDERGRAAF WTA SLEIJFER DT VANDERZEE AGJ MULDER NH
Citation: Rs. Dejong et al., PHASE-II STUDY OF INTRAPERITONEAL CISPLATIN PLUS SYSTEMIC ETOPOSIDE AS 2ND-LINE TREATMENT IN PATIENTS WITH SMALL-VOLUME RESIDUAL OVARIAN-CANCER, European journal of cancer, 31A(5), 1995, pp. 709-713
VALUE OF P-GLYCOPROTEIN, GLUTATHIONE-S-TRANSFERASE-PI, C-ERBB-2, AND P53 AS PROGNOSTIC FACTORS IN OVARIAN CARCINOMAS
Authors: VANDERZEE AGJ HOLLEMA H SUURMEIJER AJH KRANS M SLUITER WJ WILLEMSE PHB AALDERS JG DEVRIES EGE
Citation: Agj. Vanderzee et al., VALUE OF P-GLYCOPROTEIN, GLUTATHIONE-S-TRANSFERASE-PI, C-ERBB-2, AND P53 AS PROGNOSTIC FACTORS IN OVARIAN CARCINOMAS, Journal of clinical oncology, 13(1), 1995, pp. 70-78
CELL BIOLOGICAL MARKERS OF DRUG-RESISTANCE IN OVARIAN-CARCINOMA
Authors: VANDERZEE AGJ HOLLEMA HH DEBRUIJN HWA WILLEMSE PHB BOONSTRA H MULDER NH AALDERS JG DEVRIES EGE
Citation: Agj. Vanderzee et al., CELL BIOLOGICAL MARKERS OF DRUG-RESISTANCE IN OVARIAN-CARCINOMA, Gynecologic oncology, 58(2), 1995, pp. 165-178
HIGHER LEVELS OF INTERLEUKIN-6 IN CYSTIC FLUIDS FROM PATIENTS WITH MALIGNANT VERSUS BENIGN OVARIAN-TUMORS CORRELATE WITH DECREASED HEMOGLOBIN LEVELS AND INCREASED PLATELET COUNTS
Authors: VANDERZEE AGJ DECUYPER EMJ LIMBURG PC DEBRUIJN HWA HOLLEMA H BIJZET J KRANS M DEVRIES EGE
Citation: Agj. Vanderzee et al., HIGHER LEVELS OF INTERLEUKIN-6 IN CYSTIC FLUIDS FROM PATIENTS WITH MALIGNANT VERSUS BENIGN OVARIAN-TUMORS CORRELATE WITH DECREASED HEMOGLOBIN LEVELS AND INCREASED PLATELET COUNTS, Cancer, 75(4), 1995, pp. 1004-1009
MOLECULAR ANALYSIS OF THE TOPOISOMERASE-II ALPHA-GENE AND ITS EXPRESSION IN HUMAN OVARIAN-CANCER
Authors: VANDERZEE AGJ DEVRIES EGE HOLLEMA H KAYE SB BROWN R KEITH WN
Citation: Agj. Vanderzee et al., MOLECULAR ANALYSIS OF THE TOPOISOMERASE-II ALPHA-GENE AND ITS EXPRESSION IN HUMAN OVARIAN-CANCER, Annals of oncology, 5(1), 1994, pp. 75-81
TOPOISOMERASE-I AND TOPOISOMERASE-II ACTIVITY IN HUMAN BREAST, CERVIX, LUNG AND COLON-CANCER
Authors: MCLEOD HL DOUGLAS F OATES M SYMONDS RP PRAKASH D VANDERZEE AGJ KAYE SB BROWN R KEITH WN
Citation: Hl. Mcleod et al., TOPOISOMERASE-I AND TOPOISOMERASE-II ACTIVITY IN HUMAN BREAST, CERVIX, LUNG AND COLON-CANCER, International journal of cancer, 59(5), 1994, pp. 607-611
QUANTITATIVE AND QUALITATIVE ASPECTS OF TOPOISOMERASE-I AND TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-II-BETA IN UNTREATED AND PLATINUM CYCLOPHOSPHAMIDE-TREATED MALIGNANT OVARIAN-TUMORS
Authors: VANDERZEE AGJ DEJONG S KEITH WN HOLLEMA H BOONSTRA H DEVRIES EGE
Citation: Agj. Vanderzee et al., QUANTITATIVE AND QUALITATIVE ASPECTS OF TOPOISOMERASE-I AND TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-II-BETA IN UNTREATED AND PLATINUM CYCLOPHOSPHAMIDE-TREATED MALIGNANT OVARIAN-TUMORS, Cancer research, 54(3), 1994, pp. 749-755
Risultati: 1-22 |